Highland Capital Management (Tennessee)’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-12,236
Closed -$3.47M 336
2020
Q3
$3.47M Sell
12,236
-100
-0.8% -$27.9K 0.25% 113
2020
Q2
$3.3M Buy
12,336
+36
+0.3% +$10.8K 0.26% 109
2020
Q1
$3.89M Sell
12,300
-450
-4% -$137K 0.37% 79
2019
Q4
$3.78M Buy
+12,750
New +$3.54M 0.26% 107
2019
Q2
Sell
-2,801
Closed -$662K 306
2019
Q1
$662K Buy
2,801
+6
+0.2% +$1.89K 0.05% 254
2018
Q4
$841K Buy
2,795
+49
+2% +$15.6K 0.07% 230
2018
Q3
$970K Buy
2,746
+28
+1% +$9.64K 0.07% 222
2018
Q2
$789K Sell
2,718
-35
-1% -$9.84K 0.06% 230
2018
Q1
$754K Buy
2,753
+377
+16% +$117K 0.06% 242
2017
Q4
$757K Sell
2,376
-491
-17% -$158K 0.06% 222
2017
Q3
$898K Buy
2,867
+31
+1% +$9.18K 0.07% 199
2017
Q2
$770K Sell
2,836
-156
-5% -$41.3K 0.06% 213
2017
Q1
$818K Sell
2,992
-569
-16% -$161K 0.07% 212
2016
Q4
$1.01M Sell
3,561
-1,026
-22% -$304K 0.09% 202
2016
Q3
$1.44M Sell
4,587
-3,400
-43% -$1.01M 0.12% 177
2016
Q2
$1.93M Sell
7,987
-2,454
-24% -$647K 0.17% 146
2016
Q1
$2.72M Buy
10,441
+2,964
+40% +$783K 0.23% 120
2015
Q4
$2.29M Buy
7,477
+4,009
+116% +$1.15M 0.18% 146
2015
Q3
$1.01M Sell
3,468
-294
-8% -$97.1K 0.09% 234
2015
Q2
$1.52M Buy
+3,762
New +$1.51M 0.12% 212

Other funds holding BIIB

Highland Capital Management (Tennessee)'s BIIB Position: Q4 2020 in Review

Highland Capital Management (Tennessee) sold out of Biogen (BIIB) in Q4 2020, closing a stake of 12,236 shares — an estimated $3.47M sold.

Highland Capital Management (Tennessee) first reported a position in BIIB in Q2 2015 and held it in 20 quarters. The position peaked at $3.89M in Q1 2020. 1,061 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • Highland Capital Management (Tennessee) reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 12,236 Biogen shares in Q4 2020, an estimated $3.47M.
  • Highland Capital Management (Tennessee) first reported a position in Biogen in Q2 2015 and held it in 20 quarters.
  • Highland Capital Management (Tennessee)'s Biogen position peaked at $3.89M in Q1 2020.
  • 1,061 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q4 2020, filed 21 Jan 2021.